RxDoctor Payments Data

Dunnett Durando, DO

Dermatology · Cape Coral, FLNPI 1275775322

Payments from drug & device makers

$196,948in general payments, 2019–2025

Across 439 payments — averaging $448.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mindera Corp$120K
  • Amgen$57K
  • Pfizer$12K
  • Johnson & Johnson$1K
  • AbbVie$1K
  • Sanofi$774
  • plus $3K from 24 others

What the payments were for

  • Speaking & faculty fees$66,24587%
  • Travel & lodging$3800%
  • Food & beverage$9,35012%
  • Education$4921%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$196,948 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$552,985
Medicare patients
1,346
Services billed
6,162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TremfyaGuselkumab30$403,635
OtezlaApremilast48$181,766
Taltz AutoinjectorIxekizumab22$150,121
Dupixent SyringeDupilumab30$111,718
JubliaEfinaconazole18$29,540
OpzeluraRuxolitinib Phosphate11$23,989
Clobetasol Propionate288$12,270
Tacrolimus52$6,686
Calcipotriene42$5,941
Metronidazole76$4,647
Doxycycline Hyclate95$4,142
Ketoconazole294$4,138
Triamcinolone Acetonide254$3,974
Fluorouracil45$3,150
Fluocinolone AcetonideFluocinolone/Shower Cap41$2,827

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$1,423$403,63530 claims
AmgenOtezla$57,469$181,76648 claims
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$33$29,54018 claims
Incyte CorporationOpzelura$68$23,98911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,147 dermatology providers in Florida.

Other dermatology in Cape Coral

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →